Advaxis Stock Analysis (NASDAQ:ADXS)

Add to My Stocks
$8.31 $0.04 (0.48%) ADXS stock closing price Apr 25, 2017 (Closing)
Watch Robo Advisor Video of ADXS Stock Analysis
Advaxis
Updated on : Apr 25, 2017
previous close
ADXS 8.3 (0%)
S&P 500 2388.6 (0%)
Closing Price On: Apr 25, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Biomed-Genetics
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q1
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-979%
Sector Average:
0.6%
5 Quarter Net Profit
Net Margins
2017-Q1
%
LTM Margin
Debt/Equity Ratio
Debt:
0.4M
Debt/Equity Ratio:
 0
Compared to the industry
Cash Flow
Operating cash flow:
-$14.1M
Net Income:
-$17.1M
PROS      CONS
Low Debt Burden
Operating Margins
Net Margins
ROE
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Other Metrics
Return on Equity:
-69.3%
Free Cash Flow Margin:
-401.3%
Double Tap To Exit Full Screen
0:00
/

Advaxis Analysis Video

132 5 2

View Advaxis stock analysis video. This is our ADXS analyst opinion covering the buy and sell arguments for ADXS stock.

Advaxis, Inc. Stock Rating (1.2/5)

Our Advaxis stock opinion is based on fundamentals of the company. This Advaxis stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy ADXS stock?

  • Advaxis has a lower debt burden than its peers in the Medical sector, with a debt/equity ratio of  0.

Should you sell ADXS stock?

  • Advaxis registered a negative operating margin of -979% (average) over the Trailing Twelve Months (TTM).
  • Over the last 12 months, Advaxis had an average Net loss of -940.2%.
  • Advaxis has a negative return on equity of -69.3%. This indicates that the firm is inefficient at generating profits.
  • The company has a negative free cash flow margin of -401.3%.

Comments on this video and Advaxis stock